Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.
2.

Association between diabetes mellitus and mortality among patients with tuberculosis in California, 2010-2014.

Nguyen CH, Pascopella L, Barry PM.

Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1269-1276. doi: 10.5588/ijtld.18.0011.

PMID:
30355405
3.

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Beavers SF, Pascopella L, Davidow AL, Mangan JM, Hirsch-Moverman YR, Golub JE, Blumberg HM, Webb RM, Royce RA, Buskin SE, Leonard MK, Weinfurter PC, Belknap RW, Hughes SE, Warkentin JV, Welbel SF, Miller TL, Kundipati SR, Lauzardo M, Barry PM, Katz DJ, Garrett DO, Graviss EA, Flood JM; Tuberculosis Epidemiologic Studies Consortium.

Ann Am Thorac Soc. 2018 Feb 28. doi: 10.1513/AnnalsATS.201705-405OC. [Epub ahead of print]

PMID:
29490150
4.

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

Blount RJ, Pascopella L, Catanzaro DG, Barry PM, English PB, Segal MR, Flood J, Meltzer D, Jones B, Balmes J, Nahid P.

Environ Health Perspect. 2017 Sep 29;125(9):097026. doi: 10.1289/EHP1699.

5.

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015.

Oh P, Pascopella L, Barry PM, Flood JM.

BMC Res Notes. 2017 Aug 30;10(1):434. doi: 10.1186/s13104-017-2754-y.

6.

Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010-2013.

Peralta G, Barry P, Pascopella L.

Open Forum Infect Dis. 2016 Dec 5;3(4):ofw230. eCollection 2016 Oct.

7.

Factors associated with extended treatment among tuberculosis patients at risk of relapse in California.

Qin F, Barry PM, Pascopella L.

Int J Tuberc Lung Dis. 2016 Mar;20(3):363-9. doi: 10.5588/ijtld.15.0469.

PMID:
27046718
8.

Death with tuberculosis in california, 1994-2008.

Pascopella L, Barry PM, Flood J, DeRiemer K.

Open Forum Infect Dis. 2014 Oct 1;1(3):ofu090. doi: 10.1093/ofid/ofu090. eCollection 2014 Dec.

9.

Opportunities for tuberculosis diagnosis and prevention among persons living with HIV: a cross-sectional study of policies and practices at four large Ryan White Program-Funded HIV clinics.

Pascopella L, Franks J, Marks SM, Salcedo K, Schmitz K, Colson PW, Hirsch-Moverman Y, Flood J, Sayles J.

PLoS One. 2014 Jul 7;9(7):e101313. doi: 10.1371/journal.pone.0101313. eCollection 2014.

10.

Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.

Prach LM, Pascopella L, Barry PM, Flood J, Porco TC, Hopewell PC, Metcalfe JZ.

AIDS. 2013 Oct 23;27(16):2615-22. doi: 10.1097/01.aids.0000432445.07437.07.

11.

When tuberculosis comes back: who develops recurrent tuberculosis in california?

Pascopella L, Deriemer K, Watt JP, Flood JM.

PLoS One. 2011;6(11):e26541. doi: 10.1371/journal.pone.0026541. Epub 2011 Nov 1.

12.

Community-wide transmission of a strain of Mycobacterium tuberculosis that causes reduced lung pathology in mice.

Cantrell SA, Pascopella L, Flood J, Crane CM, Kendall LV, Riley LW.

J Med Microbiol. 2008 Jan;57(Pt 1):21-7.

PMID:
18065663
13.

Field assessment of a model tuberculosis outbreak response plan for low-incidence areas.

Freimanis Hance L, Steingart KR, Hahn CG, Pascopella L, Nolan CM.

BMC Public Health. 2007 Oct 26;7:307.

14.
15.

Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis.

Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL.

J Infect. 2005 Oct;51(3):175-87. Epub 2005 Jul 5.

PMID:
16002146
16.

Laboratory reporting of tuberculosis test results and patient treatment initiation in California.

Pascopella L, Kellam S, Ridderhof J, Chin DP, Reingold A, Desmond E, Flood J, Royce S.

J Clin Microbiol. 2004 Sep;42(9):4209-13.

17.

Evaluation of tuberculosis contact investigations in California.

Sprinson JE, Flood J, Fan CS, Shaw TA, Pascopella L, Young JA, Royce SE.

Int J Tuberc Lung Dis. 2003 Dec;7(12 Suppl 3):S363-8.

PMID:
14677824
18.

Use of recommended laboratory testing methods among patients with tuberculosis in California.

Kellam S, Pascopella L, Desmond E, Reingold A, Chin DP.

J Clin Microbiol. 2001 May;39(5):1969-71.

19.

A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.

George KM, Pascopella L, Welty DM, Small PL.

Infect Immun. 2000 Feb;68(2):877-83.

20.

An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae.

Philipp WJ, Poulet S, Eiglmeier K, Pascopella L, Balasubramanian V, Heym B, Bergh S, Bloom BR, Jacobs WR Jr, Cole ST.

Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3132-7.

21.

Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum.

Pascopella L, Raupach B, Ghori N, Monack D, Falkow S, Small PL.

Infect Immun. 1995 Nov;63(11):4329-35.

22.

Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex.

Collins DM, Kawakami RP, de Lisle GW, Pascopella L, Bloom BR, Jacobs WR Jr.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8036-40.

23.

Entry of microbes into the host: using M cells to break the mucosal barrier.

Jones B, Pascopella L, Falkow S.

Curr Opin Immunol. 1995 Aug;7(4):474-8. Review.

PMID:
7495510
24.

Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence.

Pascopella L, Collins FM, Martin JM, Lee MH, Hatfull GF, Stover CK, Bloom BR, Jacobs WR Jr.

Infect Immun. 1994 Apr;62(4):1313-9.

25.

Isolation and characterization of the aspartokinase and aspartate semialdehyde dehydrogenase operon from mycobacteria.

Cirillo JD, Weisbrod TR, Pascopella L, Bloom BR, Jacobs WR Jr.

Mol Microbiol. 1994 Feb;11(4):629-39.

PMID:
7910936
26.

Identification of a genomic fragment of Mycobacterium tuberculosis responsible for in vivo growth advantage.

Pascopella L, Collins FM, Martin JM, Jacobs WR Jr, Bloom BR.

Infect Agents Dis. 1993 Aug;2(4):282-4.

PMID:
8173811
27.

Screening of a cosmid library of Mycobacterium bovis BCG in Mycobacterium smegmatis for novel T-cell stimulatory antigens.

Averill LE, Cavallo U, Wallis RS, Boom WH, Bona M, Mincek M, Pascopella L, Jacobs WR Jr, Ellner JJ.

Res Microbiol. 1993 Jun;144(5):349-62.

PMID:
8248628
28.

Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium.

Belisle JT, Pascopella L, Inamine JM, Brennan PJ, Jacobs WR Jr.

J Bacteriol. 1991 Nov;173(21):6991-7.

29.
30.

Genetic systems for mycobacteria.

Jacobs WR Jr, Kalpana GV, Cirillo JD, Pascopella L, Snapper SB, Udani RA, Jones W, Barletta RG, Bloom BR.

Methods Enzymol. 1991;204:537-55. Review. No abstract available.

PMID:
1658570

Supplemental Content

Loading ...
Support Center